title: Suspected adverse events, 2013.
abstract: Increase in the number of reports of suspected adverse events in animals, Fewer reports of human adverse events to veterinary medicines, Notable increase in reports relating to products used for treating canine epilepsy. These are some of the results from the surveillance work carried out by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD), as discussed by Giles Davis and colleagues from the VMD.
authors.affiliation: Suspected Adverse Reaction Surveillance Scheme, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS.
authors.forename: G
authors.initials: G
authors.lastname: Davis
authors.affiliation: Suspected Adverse Reaction Surveillance Scheme, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS.
authors.forename: S
authors.initials: S
authors.lastname: Cooles
authors.affiliation: Suspected Adverse Reaction Surveillance Scheme, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS.
authors.forename: N
authors.initials: N
authors.lastname: Vasan
mesh_terms: D000818:Animals; D006801:Humans; D011358:Product Surveillance, Postmarketing; D006113:United Kingdom; D019155:Veterinary Drugs / Q000009:adverse effects*; D014730:Veterinary Medicine
chemical_list: D019155:Veterinary Drugs